Pyruvate kinase activators for use in treating blood disorders

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12133853
APP PUB NO 20230226055A1
SERIAL NO

18099311

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described herein are compounds that activate pyruvate kinase, pharmaceutical compositions and methods of use thereof. These compounds are represented by Formula (I) wherein R1, R2, Ra, Rb, Rj, Rk, and Q are as defined herein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AGIOS PHARMACEUTICALS INC88 SIDNEY STREET CAMBRIDGE MA 02139

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cai, Zhenwei Princeton, US 32 356
Cianchetta, Giovanni Boxford, US 28 259
Cui, Dawei Shanghai, CN 28 234
Ji, Jingjing Shanghai, CN 10 31
Liu, Tao Wellesley, US 613 3850
Padyana, Anil Kumar Lexington, US 11 64
Sui, Zhihua Audubon, US 129 723

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 May 5, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 May 5, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 5, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00